Luiz Belardinelli works in Electrophysiology affiliated with Acorda Therapeutics (United States).
Luiz Belardinelli serves as the Chief Medical Officer at InCarda Therapeutics. He previously held senior positions at Gilead Sciences and CV Therapeutics, contributing to the development of cardiovascular drugs such as Ranexa and Lexiscan. His research focuses on cardiac electrophysiology and pharmacology.
539 pubs · 26,484 cites · h-index 87
MD
Medical Catholic School of Porto Alegre
1975
Chief Medical Officer
InCarda Therapeutics · 2016 - Present
Senior Vice President, Cardiovascular Therapeutics Area
Gilead Sciences · 2009 - 2015
Senior Vice President, Translational Biomedical Research
CV Therapeutics · 1999 - 2009
Professor of Medicine, Cardiology and Pharmacology
University of Florida · 1988 - 1999
Associate Professor of Medicine, Division of Cardiology
University of Virginia · 1980 - 1988